Concepedia

Therapy Scheduling

Therapy Scheduling is a methodological framework within Alpha-Particle Therapy that determines the optimal temporal administration and dosing regimen of alpha-particle-emitting radiopharmaceuticals to maximize tumor cell eradication while minimizing radiotoxicity to healthy tissues.

250

Publications

15.8K

Citations

1.6K

Authors

522

Institutions

Publications per year

2017–2026

35

Parents

Publications

250

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.

Aimery de Gramont, J.-F. Bosset, C Milan et al. · Journal of Clinical Oncology · 1997 · 907 citations

, , +16

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.

J J Lokich, James D. Ahlgren, John J. Gullo et al. · Journal of Clinical Oncology · 1989 · 772 citations

, , +15

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

Nevin Murray, P. Coy, Joseph L. Pater et al. · Journal of Clinical Oncology · 1993 · 728 citations

, , +14

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104

Minoru Takada, Masahiro Fukuoka, Masaaki Kawahara et al. · Journal of Clinical Oncology · 2002 · 704 citations

, , +14

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

W. Robert Lee, James J. Dignam, Mahul B. Amin et al. · Journal of Clinical Oncology · 2016 · 629 citations · Full text

, , +17

1–5 of 250

Authors

1.6K

  1. LN
    Larry Norton

    Memorial Sloan Kettering Cancer Center, United States

    4 publications · 586 citations

    4

    h-index

  2. EK
    Eric K. Rowinsky

    The University of Texas at San Antonio Health Science Center, United States

    4 publications · 138 citations

    4

    h-index

  3. LT
    L. Tye

    Pfizer (United States), United States

    4 publications · 234 citations

    4

    h-index

  4. RC
    Richard C. Chao

    Mirati Therapeutics (United States), United States

    3 publications · 210 citations

    3

    h-index

  5. YC
    Yuhchyau Chen

    University of Rochester Medical Center, United States

    3 publications · 667 citations

    3

    h-index

1–5 of 1.6K

Institutions

522

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    9 h-index

    33 publications

    2.5K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    8 h-index

    71 publications

    6.1K citations

  3. Roswell Park Comprehensive Cancer Center

    Buffalo, United States

    7 h-index

    23 publications

    2.9K citations

  4. Mayo Clinic

    Rochester, United States

    7 h-index

    28 publications

    1.7K citations

  5. Washington University in St. Louis

    St Louis, United States

    6 h-index

    11 publications

    932 citations

  6. Mayo Clinic in Arizona

    Scottsdale, United States

    5 h-index

    27 publications

    1.5K citations

  7. Inserm

    Paris, France

    5 h-index

    22 publications

    496 citations

  8. Pfizer (United States)

    New York, United States

    5 h-index

    25 publications

    1K citations

1–8 of 522

Venues

  1. Journal of Clinical Oncology

    28 publications · 6K citations

    22

    h-index

  2. PubMed

    Repository · 27 publications · 1.3K citations

    17

    h-index

  3. 15

    h-index

  4. Radiotherapy and Oncology

    8 publications · 697 citations

    8

    h-index

  5. Cancer

    6 publications · 149 citations

    6

    h-index

1–5